医学
SABR波动模型
肺癌
间质性肺病
放射治疗
肺
人口
临床终点
外科
内科学
随机对照试验
波动性(金融)
随机波动
环境卫生
金融经济学
经济
作者
David A. Palma,Houda Bahig,Andrew Hope,Stephen Harrow,Brock Debenham,Alexander V. Louie,Thi Trinh Thuc Vu,Édith Filion,Andrea Bezjak,Marie‐Pierre Campeau,Adele Duimering,Meredith Giuliani,Joanna Laba,Pencilla Lang,Benjamin H. Lok,Xiaotao Qu,Srinivas Raman,George Rodrigues,Christopher D. Goodman,Stewart Gaede
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2024-03-07
卷期号:10 (5): 575-575
被引量:18
标识
DOI:10.1001/jamaoncol.2023.7269
摘要
Patients with interstitial lung disease (ILD) and early-stage non-small cell lung cancer (NSCLC) have been reported to be at high risk of toxic effects after stereotactic ablative radiotherapy (SABR), but for many patients, there are limited alternative treatment options.
科研通智能强力驱动
Strongly Powered by AbleSci AI